With FDA Clearance, Molecular Matrix Looks to Make a Lasting Clinical Impact

When Molecular Matrix founder Charles Lee first began experimenting with stem cells as an undergraduate at UC Davis, the idea of running a biotechnology startup probably seemed far fetched. With the Food and Drug Administration’s clearance of Molecular Matrix’s synthetic bone graft product Osteo-P, however, Lee now finds himself using this startup to drive significant innovations in healthcare. Perhaps most exciting for the young entrepreneur is that, thanks to UC Davis, he’s been able to be a part of the project every step of the way.

It was his mentor Alice Tarantal, a professor of pediatrics at the the UC Davis School of Medicine, who first gave him a line of stem cells to culture. Lee fell in love with the possibilities offered by his research, namely the idea of creating a polymer platform for growing these stem cells into layers. While this had certainly been done before, Lee’s solution was unique in that it utilized cross-linked carbohydrate molecules to create a structure that not only allows for stem cell growth, but also degrades once that growth is accomplished in a way that does not affect the cells themselves.

He worked on this as he completed a PhD, as well as postdoctoral work, all at UC Davis. In 2011, UC Davis believed in the work so much that they helped him found Molecular Matrix. The company used this polymer structure that Lee had created and managed to develop a product, Osteo-P, that would help bones regrow, this time without stem cell transplantation.

This is particularly impactful for patients who have had bone removed in surgery and as the graft acts as a support and guide for the patient’s own bone growth. This means that, eventually the grafted Osteo-P will be completely replaced with new bone growth. For the university, their involvement in Molecular Matrix, and their inter-departmental commitment to its success, is a prime example of how it is able to make a lasting societal impact.

With the recent announcement that Osteo-P has cleared FDA regulations for clinical use, Lee is experiencing a dream realized. He has surrounded himself with a passionate and engaged team, receives help from the university to attract funding, and continues to offer students opportunities to work with Molecular Matrix both as interns and employees. Just as his professor had done when he started, Lee is helping to encourage a love for polymer development and stem cell research in the newest generation of student scientists.

Follow us on social media for the latest updates in B2B!

Image

Latest

human-centered
How Human-Centered Design Led to a Startup Accelerator for Education: A Conversation with Transcend Network’s Co-founder Michael Narea
June 20, 2025

The convergence of human-centered design and education innovation is reshaping how edtech ventures emerge and scale. As AI enables hyper-efficiency and bootstrapped entrepreneurship becomes more viable, the real differentiator is empathy—founders who listen deeply to users before building solutions. A McKinsey study of 300 public companies found that design-led organizations significantly outperformed their peers, with…

Read More
care navigation
AI-Powered Care Navigation Reduces Healthcare Spend and Improves Patient Access
June 20, 2025

The U.S. healthcare system is strained by rising costs, uneven quality, and fragmented care navigation. Employers are bearing the brunt, spending more without always securing better care for their teams. According to the RAND Corporation, one effective strategy is to “change their network and benefit designs to encourage patients to use lower‑priced, higher‑value providers…

Read More
edge computing
Building the Wireless Future: Low-Power IoT, Edge Computing, and the End of the Gs
June 19, 2025

As the global race to 6G heats up, telecom providers, governments, and tech companies are investing billions to advance the next generation of hyperconnected infrastructure. European operators urge regulators to release more spectrum to stay competitive, while U.S. programs like the USDA’s ReConnect have funneled over $1 billion into rural fiber backhaul. Meanwhile, companies like…

Read More
healthcare operations
Healthcare Operations Improve with AI That Unites Data, Automation, and Ethics
June 18, 2025

Generative AI has captured the public imagination, but its most transformative use cases may lie far from flashy consumer tools. In healthcare operations, where complexity, inefficiency, and fragmentation remain persistent challenges, AI is now driving measurable improvements. Research suggests AI-enabled healthcare systems could cut administrative costs by up to $360 billion in the U.S. alone….

Read More